News

Buffett's Bold Move: Berkshire Expands Its Occidental Holdings

Buffett's Bold Move: Berkshire Expands Its Occidental Holdings

Berkshire Hathaway's Investment in Occidental Petroleum

After a lengthy pause in activity, Warren Buffett and Berkshire Hathaway (NYSE: BRKa) have made headlines again by purchasing additional shares of Occidental Petroleum (NYSE: OXY). This move comes after a period of multi-year low share prices, which presented a significant opportunity for investment. The recent acquisitions amount to about 8 million shares, increasing Berkshire's total stake to roughly 30% of Occidental's stock. Additionally, they hold warrants representing about 10% of the stock, along with preferred shares acquired in 2018 that have been pivotal for Berkshire's strategy.

Warren Buffett's Insight on Financial Improvement

The motivation behind Berkshire's latest purchases goes beyond mere numbers; it reflects a growing confidence in Occidental's financial resurgence. As Occidental has been shedding debt, notably the preferred shares that Berkshire initially bought, it appears that Buffett is banking on a brighter future for the company. The most recent financial results indicate a mix of challenges and strengths, largely due to fluctuating oil prices. While revenues saw a dip, Occidental's production levels improved, bolstering margins and demonstrating a solid free cash flow of approximately $1.5 billion.

Notably, Occidental's balance sheet reveals increased net debt, which is counterbalanced by a threefold increase in cash. This trend indicates a healthy liquidity position, supported by growing current assets. Equity has risen by around 18%, signaling a robust financial foundation. With cash reserves exceeding $1.8 billion and a low net-debt leverage ratio of less than 0.75x equity, the company seems well-equipped to withstand economic fluctuations.

Strong Prospects for Dividends and Growth

Another advantage of Occidental’s improved cash flow is its capability to maintain and potentially increase dividends. For 2024, it is projected that dividends will amount to about 25% of the earnings forecast, with room for growth indicated. Analysts expect earnings to continue rising into 2025, fueled by a positive economic environment characterized by lowered interest rates and reduced regulatory challenges. The imminent distribution increase in early 2025 is expected to be notable, likely reflecting double-digit growth due to this positive trend.

Market Analysts and Institutional Support

Support for Occidental's stock price is bolstered by market analysts and institutional investors, with a consensus indicating a robust outlook for 2024. Although some analysts have reduced their price targets, the consensus still suggests potential upside, reinforced by a Hold/Moderate Buy rating. The anticipated growth reflects a balanced approach, ensuring that even the lower end of the target range offers support above recent trading values.

Institutions, while initially bearish in the third quarter, have resumed buying shares in the fourth quarter, signaling renewed confidence. Excluding Berkshire, institutional investors control approximately 50% of the stock, which contributes significantly to the share price stability. Including Berkshire's holdings, nearly 80% of Occidental's shares are held by institutions, further solidifying its market standing.

Technical Indicators Suggest Bullish Momentum

Occidental Petroleum's stock has shown resilience, bouncing back from multi-year lows recorded in December. Technical indicators suggest a bullish momentum is on the horizon. The MACD and stochastic indicators are currently favoring an upward trend. Stochastic indicators have already registered positive crossovers at critical support levels, while the MACD is poised to follow suit shortly. This positive technical setup could see the stock rise, potentially reaching the consensus target price of $62 by early 2025.

Frequently Asked Questions

What does Berkshire Hathaway’s investment in Occidental mean?

Berkshire's investment reflects confidence in Occidental's financial recovery and future growth prospects, which could bode well for shareholders.

How has Occidental Petroleum's financial health changed recently?

Occidental has improved its financial health by reducing debt and increasing cash flow, despite some challenges in revenue due to oil prices.

What are the dividend prospects for Occidental Petroleum?

The outlook for dividends is positive, with expectations of increases due to strong earnings growth anticipated in the coming years.

How supportive are analysts of Occidental's stock price?

Many analysts maintain a Hold/Moderate Buy rating for Occidental, highlighting potential upside despite mixed results in the past year.

What technical indicators suggest about Occidental’s stock movement?

Technical indicators are currently signaling bullish trends for Occidental, suggesting a possible rise in stock price heading into 2025.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 280

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 84

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 21

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 299

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 175

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 98

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

Morgan Stanley Projects Strong Upswing for Consumer Finance

Updated Category News Views 259

Morgan Stanley's Positive Outlook for Consumer Finance Stocks Morgan Stanley has recently made an uplifting adjustment to its outlook on consumer finance stocks, now branding them as "attractive." This decision stems from robust fundamentals and an improved regulatory environment, setting an optimistic tone for the sector. Key Drivers of Change The primary catalysts...

Continue Reading
Significant Board Restructuring at O2Gold Inc. Announced

Updated Category News Views 71

O2Gold Board Announces Key Changes O2Gold Inc. (NEX: OTGO.H), a dedicated mineral exploration company, has recently undergone a significant change in its board structure. The company has announced that Roger Lemaitre has resigned from his position as a director. This decision marks a pivotal moment for O2Gold as it continues to navigate its exploration initiatives....

Continue Reading
Taylor Morrison Launches Holiday Initiative to Support Homeowners

Updated Category News Views 265

Help for Homeowners During the Holidays In a time when financial strain can be prominent, especially during the holidays, Taylor Morrison (NYSE: TMHC) is stepping up to lend a hand. The renowned homebuilder has introduced an initiative designed to support homeowners facing the threat of foreclosure. With the holiday season often heightening financial challenges, the...

Continue Reading
flatexDEGIRO Moves Ahead After Ending BaFin Oversight

Updated Category News Views 188

flatexDEGIRO Ends Special Commissioner Mandate FRANKFURT - flatexDEGIRO AG, a prominent German financial services provider, has officially announced the conclusion of the special commissioner mandate set by the Federal Financial Supervisory Authority (BaFin). This change will take effect on a specified date in the future. The company has made significant strides in...

Continue Reading
Investigating Alvotech's Regulatory Challenges After Stock Drop

Updated Category News Views 125

Alvotech Faces Scrutiny over Manufacturing Issues National shareholder rights firm Hagens Berman is currently analyzing Alvotech (NASDAQ: ALVO) regarding potential misrepresentations in their disclosures tied to manufacturing operations and the regulatory status of their primary biosimilar candidate, AVT05. Impact of FDA's Complete Response Letter The investigation stems...

Continue Reading